Guided Therapeutics, Inc. Books Investment, Signs MOU With Potential China Distributor

Guided Therapeutics of the US booked $720,000 from a group of unidentified investors and signed an MOU to negotiate China distribution rights for a cervical cancer screening device, the LuViva® Advanced Cervical Scan. The investment bought 4 million shares Guided Therapeutics stock and warrants for an additional 2 million shares. The shares are worth $560,000 at the current price.

Help employers find you! Check out all the jobs and post your resume.

Back to news